The Pan African Medical Journal (May 2019)

A multi-centre evaluation of malignant odontogenic tumours in Nigeria

  • Olujide Oladele Soyele,
  • Olajumoke Ajibola Effiom,
  • Ahmed Oluwatoyin Lawal,
  • Mark Chukwuemeka Nwoga,
  • Kehinde Emmanuel Adebiyi,
  • Adetayo Aborisade,
  • Abiodun Saheed Olatunji,
  • Adetokunbo Babajide Olawuyi,
  • Adeola Mofoluwake Ladeji,
  • Robinson Obos Okiti,
  • Henry Ademola Adeola

DOI
https://doi.org/10.11604/pamj.2019.33.18.16179
Journal volume & issue
Vol. 33, no. 18

Abstract

Read online

INTRODUCTION: Odontogenic tumors originate from neoplastic transformation of the remnants of tooth forming apparatus. There are varying degrees of inductive interactions between odontogenic ectomesenchyme and epithelium during odontogenesis, leading to lesions that vary from benign to malignant. Malignant odontogenic tumours (MOTs) are very rare and are classified according embryonic tissue of origin. Recently, there has been a few changes to the classification of MOTs according to the World Health Organization's (WHO) classification in 2017. This study aims to evaluate and reclassify MOTs, using a multi-centre approach in some major tertiary dental hospitals in Nigeria. METHODS: this study reviewed the clinicopathological data on 63 cases of MOT diagnosed over 25 years in five major tertiary dental hospitals in Nigeria. All MOT cases were reclassified according to the recent revision to the 2017 WHO classification of odontogenic tumours. RESULTS: from a total of 10,446 biopsies of oral and jaw lesions seen at the 5 study centres over the 25-year study period, 2199 (21.05%) cases were found to be odontogenic tumours (OTs), of which 63 were MOT. MOTs constituted (0.60%) of the total biopsy cases and 2.86% of OTs. Odontogenic carcinomas presented with a mean age higher than odontogenic sarcomas. According to our 2017 WHO reclassification of MOTs, odontogenic carcinomas, ameloblastic carcinomas and primary intraosseous carcinomas were found to be the top three lesions, respectively. Carcinosarcomas were found to be extremely rare. CONCLUSION: using a multi-centre approach is a robust way to reduce diagnostic challenges associated with rare maxillofacial lesions such as MOTs.

Keywords